Vertex Pharmaceuticals Incorporated v. United States Department of Health and Human Services

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA VERTEX PHARMACEUTICALS INCORPORATED, Plaintiff, v. Civil Action No. 24-2046 (JEB) UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES, et al., Defendants. MEMORANDUM OPINION Vertex Pharmaceuticals Incorporated has developed an innovative gene-editing therapy to treat — and potentially cure — two serious blood disorders: sickle-cell disease and transfusion- dependent beta-thalassemia. Patients who receive the therapy (called CASGEVY) must first undergo chemotherapy, which can have severe adverse effects on their fertility. Worried…